FG | Range | CV | |
---|---|---|---|
% | |||
Atorvastatin | 0.83 | 0.73–0.90 | 8 |
Buspirone | 0.65 | 0.48–0.85 | 24 |
Cyclosporine | 0.84 | 0.71–0.94 | 11 |
Felodipine | 0.11 | 0.06–0.17 | 42 |
Indinavira | 0.94 | 0.92–0.98 | 3 |
Lovastatin | 0.08 | 0.03–0.16 | 59 |
Midazolam | 0.33 | 0.19–0.52 | 36 |
Nisoldipine | 0.04 | 0.02–0.07 | 53 |
Saquinavira | 0.36 | 0.19–0.55 | 39 |
Simvastatin | 0.03 | 0.02–0.06 | 45 |
Tacrolimusa | 0.08 | 0.03–0.15 | 58 |
Terfenadinea | 0.12 | 0.03–0.23 | 65 |
a Based on apparent permeability (apical-basolateral) data in the presence of a P-glycoprotein inhibitor.